BioSpace News Archive

Genetown

Takeda Named Global Top Employer for Seventh Consecutive Year

Takeda ( TSE:4502/NYSE:TAK ) today announced that for the seventh consecutive year, it has received global Top Employer® certification for 2024.

January 18, 2024
·
4 min read
Business

KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS

Kazia Therapeutics Limited is pleased to announce the appointment of pharma industry executive, Mr. Robert Apple to Kazia’s Board of the Directors (the “Board”) as a Non-Executive Director.

January 18, 2024
·
5 min read
BioCapital

Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split

Processa Pharmaceuticals, Inc. announces that in conjunction with stockholder approval of the reverse stock split on November 14, 2023, the Company’s Board of Directors, on January 8, 2024, determined to fix a split ratio of 1-for-20.

January 18, 2024
·
5 min read
Business

VectorY Appoints Khurem Farooq to Board of Directors

VectorY Therapeutics today announced the appointment of industry veteran Khurem Farooq as independent board member, effective immediately.

January 18, 2024
·
3 min read
Business

Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer

Envision Pharma Group (Envision) has appointed Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team.

January 18, 2024
·
2 min read
FDA

Bone Health Technologies Announces FDA Clearance of OsteoboostTM, the First Prescription Medical Device to Treat Low Bone Density

Bone Health Technologies today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for Osteoboost TM , the first non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia (low bone density).

January 18, 2024
·
4 min read
ONWARD® Announces Start of HemON NL Clinical Study HemON NL is evaluating the use of ARC-IM® Therapy to address hemodynamic instability after spinal cord injury

ONWARD Medical N.V. announces the start of the HemON NL clinical feasibility study at Sint Maartenskliniek in Nijmegen, the Netherlands.

January 18, 2024
·
5 min read
Business

Iktos announces the appointment of Avirup Bose as Chief Business Officer

Iktos announces the appointment of Avirup Bose as Chief Business Officer.

January 18, 2024
·
3 min read
Pharm Country

Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today provided an update on its bendamustine intellectual property portfolio.

January 18, 2024
·
7 min read
Genetown

SmartLabs Announces $48 Million Series C Funding to Advance Its Laboratory Infrastructure and Resourcing Solutions

SmartLabs , the leading provider of flexible laboratory infrastructure and resourcing solutions, today announced the raise of a $48 million Series C financing.

January 18, 2024
·
3 min read